Basic Information
Basic information for SNHG14-326-62aa
Peptide Name SNHG14-326-62aa
Genome Position chr15:25271524-25271534,25277367-25277409,25278847-25278884,25391596-25391689[+]
Species Human
Peptide Sequence MPLWLKAETTSRKLQGKEKAWNLILHFREQGEKSACEILLLIHLLALSSTCQEQEGIVAGRQ
Peptide Length 62
Unique No (SNHG14-286-62aa)
Grand Average of Hydropathicity -0.2016
Relative Molecular Mass 8145.21
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000669867;SNHG14-326
Transcript Length 4483
Coding Ability 0.499
DNA Sequence Corresponding to Peptide ATGCCACTCTGGTTAAAAGCTGAAACAACTTCAAGGAAACTTCAGGGAAAAGAGAAGGCCTGGAATCTGATCCTCCACTTCAGAGAACAGGGAGAAAAAAGTGCATGTGAAATACTACTACTTATCCATCTCCTGGCTCTGAGCAGTACATGTCAGGAACAAGAGGGAATTGTAGCTGGAAGACAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :